GSA Capital Partners’s Inspire Medical Systems INSP Stock Holding History

GSA Capital Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$820K	Buy	18,382 +3,814	+26%	+$181K	0.05%	637
2026 Q1	$751K	Buy	14,568 +5,353	+58%	+$375K	0.05%	641
2025 Q4	$850K	Buy	+9,215	New	+$882K	0.07%	456
2023 Q3	–	Sell	-820	Closed	-$266K	–	1688
2023 Q2	$266K	Sell	820 -144	-15%	-$41.1K	0.03%	1115
2023 Q1	$226K	Buy	+964	New	+$244K	0.02%	1195
2022 Q4	–	Sell	-1,237	Closed	-$219K	–	1660
2022 Q3	$219K	Buy	1,237 +130	+12%	+$26.1K	0.03%	1159
2022 Q2	$202K	Buy	+1,107	New	+$221K	0.03%	1065
2022 Q1	–	Sell	-1,555	Closed	-$358K	–	1601
2021 Q4	$358K	Buy	+1,555	New	+$380K	0.05%	815

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GSA Capital Partners's INSP Position: Q2 2026 in Review

GSA Capital Partners increased its Inspire Medical Systems (INSP) stake by 26% in Q2 2026, buying an estimated $181K and bringing the position to 18,382 shares worth $820K. The position accounts for 0.05% of the portfolio, ranked #637.

GSA Capital Partners first reported a position in INSP in Q4 2021 and has held it in 8 quarters since. The position peaked at $850K in Q4 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

GSA Capital Partners held 18,382 shares of Inspire Medical Systems worth $820K as of Q2 2026.
GSA Capital Partners bought 3,814 Inspire Medical Systems shares in Q2 2026, an estimated $181K.
Inspire Medical Systems made up 0.05% of GSA Capital Partners's portfolio in Q2 2026, its #637 holding.
GSA Capital Partners first reported a position in Inspire Medical Systems in Q4 2021 and has held it in 8 quarters since.
GSA Capital Partners's Inspire Medical Systems position peaked at $850K in Q4 2025.
275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.